Lanean...
Vepoloxamer enhances fibrinolysis of tPA on acute ischemic stroke
BACKGROUND AND PURPOSE: Thrombolytic treatment of acute ischemic stroke with tissue plasminogen activator (tPA) is hampered by its narrow therapeutic window and potential hemorrhagic complication. Vepoloxamer is a nonionic surfactant that exerts potent hemorheologic and antithrombotic properties in...
Gorde:
| Argitaratua izan da: | Stroke |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6878196/ https://ncbi.nlm.nih.gov/pubmed/31587657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.119.026049 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|